How to Buy Nurix Therapeutics Stock
Nurix Therapeutics Inc
Nurix Therapeutics, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders.
Nurix Therapeutics stock last closed at $12.36, down 10.11% from the previous day, and has increased 22.26% in one year. It has overperformed other stocks in the Biotechnology industry by 0.46 percentage points. Nurix Therapeutics stock is currently +192.89% from its 52-week low of $4.22, and -31.79% from its 52-week high of $18.12.
There are currently 49.15M shares of NRIX outstanding. The market capitalization of NRIX is $607.50M. In the last 24 hours, 965,638 NRIX shares were traded.
How to Buy Nurix Therapeutics Stock
Wondering how to invest in Nurix Therapeutics stock? Here's how.
- Decide where to buy Nurix Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Nurix Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your method of payment and add your information.
- Research Nurix Therapeutics stock: The Nurix Therapeutics ticker symbol is NRIX. Is Nurix Therapeutics stock a good investment? Should you buy shares of NRIX? How do NRIX's underlying business fundamentals look? Do top analysts think Nurix Therapeutics is a good buy? Why has NRIX's stock price moved recently? (Hint: Our stock research website can help you figure out if NRIX is a good stock to buy).
- Place your NRIX purchase: Decide if you will purchase NRIX shares at the current market price or use a limit order to purchase NRIX stock at a given price.
- Get updates on your investment in NRIX: Create a watchlist to important notifications about your investment in Nurix Therapeutics shares.
Step 1: Decide where to buy Nurix Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy NRIX shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Tech to Healthcare, New York to Hong Kong — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal details so you can invest in NRIX today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've filled out your info on app for investing, your next step is to transfer the money for your investment:
Check out the video below to see the process of depositing funds into your new investment account.
Step 4: Research Nurix Therapeutics stock
After you have decided on the best place to buy Nurix Therapeutics stock, it's critical to research their stock prior to investing, so you truly comprehend the risk as well as the opportunity.
Nurix Therapeutics shares at a glance
Nurix Therapeutics Due Diligence Checks
WallStreetZen was built to help average investors perform more accurate fundamental analysis.
You can see all of the due diligence checks on NRIX's stock page.
What is the fair value of NRIX stock?
Analysts use many financial metrics, analyses, models, and charts to gauge NRIX's fair value.
Using relative valuations ratios:
- NRIX may be undervalued based on its P/B ratio of 3.6x, relative to Biotechnology industry P/B ratio of 5.8x
You can do additional valuation analysis on NRIX's stock here.
NRIX Financials at a glance
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the NRIX balance sheet.
- NRIX has $244.89M in cash and short term investments. This is enough to cover its annual cash burn of $83.87M.
- NRIX has cash burn of 83872000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the NRIX balance sheet.
Negative Health Checks:
- NRIX has a relatively high debt to equity ratio of 0.85.
- NRIX profit margin has gone up by 2.49 percentage points in the past year, but the company is still unprofitable.
Do Wall Street analysts think it's a good time to buy NRIX stock
Out of 6 sell side analysts who monitor NRIX, the consensus analyst rating on Nurix Therapeutics is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent NRIX Analyst Ratings
Derek Archila, a top 3% analyst from Wells Fargo maintains NRIX with a strong buy rating and lowers their NRIX price target from $23.00 to $20.00, on Feb 16, 2024.
You can dig deeper into what analysts are forecasting on the Nurix Therapeutics stock forecast page.
NRIX Technicals
NRIX Performance Metrics
Last year, NRIX revenue was $80.89M. In the last three year, NRIX's revenue has gone up by 145.04% per year. This was faster than the Biotechnology industry average of 28.62%.
You can research NRIX's earnings and revenue performance here.
Who is buying/selling NRIX?
In the last 12 months, executives and large shareholders at NRIX have sold more shares than they have bought.
Houte Hans Van, Chief Financial Officer of NRIX, was the latest NRIX insider to sell. They sold $68,222.18 worth of NRIX stock on Feb 16, 2024.
Dig into more about who owns NRIX shares here.
Does NRIX provide a stable income stream?
No, Nurix Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about NRIX
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your NRIX purchase
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at an exact dollar amount limit, use a limit order.
Hit the Open button and eToro will place the order.
If you need more help with buying stocks on eToro, watch the how to video below:
Step 6: Get updates on your investment in NRIX
Now that you own some NRIX shares, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to track the latest developments regarding your NRIX stock.
NRIX Feed
How to Buy Stock in Nurix Therapeutics
To reiterate, here are the 6 steps to buy Nurix Therapeutics stock:
- Decide where to buy Nurix Therapeutics stock
- Create a brokerage account
- Deposit funds into your investment account
- Research Nurix Therapeutics stock
- Place your NRIX purchase
- Get updates on your investment in NRIX
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your investment in Nurix Therapeutics, create a watchlist today.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.